Profil bibliographique

Emmanuelle Bompas

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

357Publications signalées

13682Citations signalées

2Affiliations récentes

Institutions déclarées

Institut de Cancérologie de l'Ouest Nantes Université

Domaines associés

Sarcoma Diagnosis and TreatmentGastrointestinal Tumor Research and TreatmentCardiac tumors and thrombiVascular Tumors and AngiosarcomasSoft tissue tumor case studies

Publications récentes

2026 articleOpenAlex

Deni Study: Real‐World Data on the Use of Nirogacestat in Patients With Desmoid Tumors in the French Sarcoma Group

Pierre Kubicek, Catherine Guérin‐Charbonnel, Maud Toulmonde, Pascaline Boudou‐Rouquette et autres

0 citationsInternational Journal of Cancer

2026 articleOpenAlex

Prospective SAJAC Study of Rehabilitation for Adolescents and Young Adults with Cancer in a Comprehensive Cancer Center

Emmanuelle Bompas, Audrey Blanc Lapierre, Josselin Sebille, Sophie Allain et autres

0 citationsJournal of Adolescent and Young Adult Oncology

Accès ouvert 2026 articleOpenAlex

MiT fusions, TSC1–TSC2 divergence, and stem-like programs reveal distinct origins and vulnerabilities in PEComa

Justine Gantzer, Xiaofan Lu, Céline Charon‐Barra, Charles Vinson et autres

0 citationsNature Communications

Accès ouvert 2026 datasetOpenAlex

Economic evaluation of adjuvant chemotherapy for non-metastatic sarcoma using the real-world data from the French nationwide DEEPSARC study

Lionel Perrier, Magali Morelle, Sylvie Bonvalot, Daniel Orbach et autres

0 citationsFigshare

Accès ouvert 2026 datasetOpenAlex

Economic evaluation of adjuvant chemotherapy for non-metastatic sarcoma using the real-world data from the French nationwide DEEPSARC study

Lionel Perrier, Magali Morelle, Sylvie Bonvalot, Daniel Orbach et autres

0 citationsFigshare

Accès ouvert 2026 articleOpenAlex

Economic evaluation of adjuvant chemotherapy for non-metastatic sarcoma using the real-world data from the French nationwide DEEPSARC study

Lionel Perrier, Magali Morelle, Sylvie Bonvalot, Daniel Orbach et autres

1 citationJournal of Medical Economics

Accès ouvert 2026 articleOpenAlex

Metastatic Ewing Sarcoma, Patterns of Care and Outcomes of Patients in a Real‐Life National Setting Over a Decade

Coline Ducrot, Derek Dinart, Maëva Bonneau, Max Piffoux et autres

0 citationsCancer Medicine

Accès ouvert 2026 articleOpenAlex

Overall survival of patients with localized soft tissue sarcoma treated with or without adjuvant chemotherapy (DEEPSARC): a real world nationwide retrospective cohort study in France

Jean-Yves Blay, V. Thevenet, Emmanuel Oger, Axel Le Cesne et autres

3 citationsEClinicalMedicine

2026 conference-abstractOpenAlex

PEMBROCABOSARC: A phase II trial combining pembrolizumab and cabozantinib in patients with advanced undifferentiated pleomorphic sarcoma.

Maud Toulmonde, Marina Pulido, Benjamin Verret, Audrey Monneur et autres

0 citationsJournal of Clinical Oncology

2026 conference-abstractOpenAlex

Benefit of adjuvant therapy in high-risk GIST: A large-scale real-world analysis of 2,166 patients (DEEPSARC study).

Nicolas Penel, V. Thevenet, Noémie Huchet, Jean François Emile et autres

0 citationsJournal of Clinical Oncology

2026 articleOpenAlex

INST’AJA: a co-designed Instagram campaign to promote sexual health education and behaviors in adolescent and young adult cancer survivors

Baptiste Sauterey, Pierre Kubicek, Clémence Herrenschmidt, Pauline Pannetier et autres

0 citationsThe Journal of Sexual Medicine

Accès ouvert 2026 articleOpenAlex

85MO Cabozantinib as maintenance therapy in high grade uterine sarcoma after stabilization or response to doxorubicin +/- ifosfamide regimen: Results from EORTC 62113-55115-STBSG-GCG (NCT01979393), randomized double-blind phase II study

I. Ray-Coquard, Helen Hatcher, A. Casado Herráez, R. Jones et autres

0 citationsESMO rare cancers.

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.